×

Youk J, Park H, Jin KN, Moon HJ, Yang MS, Kim KH, Kim JS (corresponding author). Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma. Korean J Intern Med. 2017 May;32(3):563-565.

S Park, HY Kim, H Kim, JH Park, JH Kim, KH Kim, W Kim, IS Choi, YJ Jung, JS Kim (corresponding author). Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome. Medicine (Baltimore). 2016 Jan;95(2):e2454

JS Kim, SC Lee, HY Min, et al, Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors. Cancer Lett. 2015 Jun 1;361(2):197-206

JS Kim, ES Kim, Liu D et al., Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer. Oncotarget. 2015 Jun 30;6(18):16746-56.

JS Kim, ES Kim, DD Liu et al., Prognostic Implications of Tumoral Expression of Insulin Like Growth Factors 1 and 2 in Patients With Non?Small-Cell Lung Cancer. Clin Lung Cancer. 2014 May;15(3):213-21

JS Kim, ES Kim, DD Liu et al., Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer. 2012 May 1;118(9):2454-65

WN William, JS Kim (equal contribution), DD Liu et al., The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann Oncol. 2012 Jan;23(1):78-85.

JS Kim, MA Kim, DY Oh et al., Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: A retrospective study. Jpn J Clin Oncol. 2011;41:245-52

HS Han, JS Kim (equal contribution), JH Park et al., Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy. J Korean Med Sci. 2009 Oct;24(5):910-7

JS Kim, MA Kim, TM Kim et al., Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival. Br J Cancer. 2009 Mar 10;100(5):732-8.

HC Cho, HM Park, JS Kim (corresponding author) et al., The syndrome of inappropriate antidiuretic hormone secretion with olfactory neuroblastoma: A case report. Korean J Med 76:S158-S163, 2009